v3.24.1.u1
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Assets    
Cash and cash equivalents $ 69,200 $ 91,187
Restricted cash 127,353 114,829
Loans receivable at fair value 2,841,525 2,962,352
Capitalized software and other intangibles, net 106,370 114,735
Right of use assets - operating 18,915 21,105
Other assets 114,138 107,680
Total assets 3,277,501 3,411,888
Liabilities    
Secured financing 72,106 289,951
Asset-backed notes at fair value 1,701,854 1,780,005
Asset-backed borrowings at amortized cost 787,524 581,468
Acquisition and corporate financing 243,413 258,746
Lease liabilities 25,472 28,376
Other liabilities 65,160 68,938
Total liabilities 2,895,529 3,007,484
Stockholders' equity    
Common stock, $0.0001 par value - 1,000,000,000 shares authorized at March 31, 2024 and December 31, 2023; 35,861,277 shares issued and 35,589,254 shares outstanding at March 31, 2024; 34,741,076 shares issued and 34,469,053 shares outstanding at December 31, 2023 7 7
Common stock, additional paid-in capital 588,562 584,555
Retained deficit (200,288) (173,849)
Treasury stock at cost, 272,023 shares at March 31, 2024 and December 31, 2023 (6,309) (6,309)
Total stockholders’ equity 381,972 404,404
Total liabilities and stockholders' equity $ 3,277,501 $ 3,411,888

Source

HTML PDF
XBRL
ZIP